This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

General Anesthesia Drugs Market

Market Insights on General Anesthesia Drugs covering sales outlook, demand forecast & up-to-date key trends

General Anesthesia Drugs Market By Drug Class (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam), Route of Administration (Intravenous Anesthesia, Inhaled Anesthesia), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) & Region - Forecast 2019 - 2029

GENERAL ANAESTHESIA DRUGS MARKET - KEY RESEARCH FINDINGS

  • The global general anaesthesia drugs market size in 2018 was ~US$ 4.2 Bn.
  • The general anaesthesia drugs market is expected to grow at a CAGR of ~3% during the forecast period of 2019-2029.
  • General anaesthesia drugs are widely used in several surgeries, and increase in the number of cardiovascular and other diseases is expected to fuel the growth of the general anaesthesia drugs market. Moreover, the availability of technologically advanced drug delivery devices and the development of specific targeted drugs is likely to foster the growth of the general anaesthesia drugs market. In addition, the proliferating general anaesthesia drugs portfolio and the number of clinical trials for the development of general anaesthesia drugs with respect to specific indications is expected to foster substantial revenue generation in the general anaesthesia drugs market.
  • Collectively, North America and Europe are likely to contribute a significant share in the general anaesthesia drugs market by the end of 2029.
    • North America continues to be a prominent regional market for general anaesthesia drugs manufacturers owing to an increase in the adoption of novel therapeutics as well as the launch of new general anaesthesia drugs into the market.
    • Europe has also witnessed significant growth in the general anaesthesia drugs market owing to an increasing number of surgeries and the rising demand for the latest technologies and healthcare facilities.
  • East Asia is likely to witness growth in the general anaesthesia drugs market due to increasing disposable income and the emergence of several cost-effective generic drugs.
  • Propofol is expected to remain a prominent drug class segment in the general anaesthesia drugs market.
    • Due to its lipophilic nature and rapid onset of action with minimal side effects, the general anaesthesia drug Propofol is highly preferred for surgeries.
Customize this Report

Let us know your requirement to get
100% FREE customization

KEY FACTORS SHAPING THE GENERAL ANAESTHESIA DRUGS MARKET

  • Increasing Demographic Trends in the Geriatric Population to Boost the General Anaesthesia Drugs Market

People aged 65 years and above are more prone to chronic diseases, due to which they are likely to require a larger number of procedures. According to a Population Reference Bureau report in 2016, the number of Americans aged 65 and above is projected to be 98 million by 2060, and the group share of the elderly population from the total population is estimated to be nearly 24%. Moreover, the increasing burden of cardiovascular diseases that require surgeries is fuelling the growth of the general anaesthesia drugs market.

In addition, the increasing frequency of co-morbidities among the aging population increases the risk of toxicities and surgical complications related with general anaesthetics. The rising population and increase in the number of procedures that require anaesthesia are some of the factors that are likely to spur the growth of the general anaesthesia drugs market.

  • Rising Utilization of Anaesthesia Drugs for Outpatient Procedures to Contribute Significantly to the Growth of the General Anaesthesia Drugs Market

Ambulatory anaesthesia provides rapid recovery from general anaesthesia drugs, which leads to the early discharge of patients and, at the same time, provides several benefits to healthcare providers, patients, as well as third-party payers and hospitals. The number of ambulatory surgeries has been increasing at an alarming rate due to continuous improvements in general anaesthesia drugs & related techniques, and the easy availability of short-acting anaesthetics with minimal side effects. Moreover, appropriate discharge criteria and the availability of minimal invasive surgical techniques has led to an increase in the adoption of ambulatory surgeries.

Furthermore, an increasing number of minimally invasive diagnostic and surgical procedures that are performed on an outpatient basis require a large number of general anaesthesia drugs. General anaesthesia drugs have the potential to impact on the efficacy as well as the cost of care in these outpatient settings. Thus, the general anaesthesia drugs market is estimated to register significant growth due to an increase in the number of surgeries performed in outpatient settings.

  • Rising Launch of New Anaesthetic Drugs Expected to Propel the Growth of the General Anaesthesia Drugs Market

Manufacturers are focusing on the launch of new anaesthetic drugs. For instance, Vétoquinol, in collaboration with Jurox Pty. Ltd., will soon launch a new injectable anaesthetic. Manufacturers are also engaged in entering into various collaboration and licensing agreements to ensure the global availability of their products. Collaboration partners seek regulatory approval for the launch and commercialisation of their products in different geographies.

For instance, in September 2017, AstraZeneca and Aspen announced that they have entered into an agreement for the remaining rights to anaesthetics medicines. Moreover, various manufacturers aim at expanding and accelerating their pipeline drugs portfolio for the launch of new general anaesthesia drugs into the market.

For instance, Paion UK Ltd.’s lead candidate, Remimazolam (CNS7056), which is an intravenous general anaesthesia drugs, has submitted an NDA filing in 2018. Thus, rising research and development and the launch of new drugs is expected to significantly drive the general anaesthetic drugs market.

General Anesthesia Drugs Market Download Report Brochure

Surgical Complexities and Patient Safety Expectations to Drive New Developments

The migration of health care systems from ‘fee-for-service (FFS)’ to ‘pay-for-performance (P4P)’ models have been forcing the healthcare professionals to reevaluate how they approach the delivery of care. Over the years, a large number of intravenous and inhalation agents of general anesthesia drugs have been introduced, and in parallel various drugs have undergone clinical usage and then withdrawn when found unreliable.

The development of safer drugs were propelled by increasing surgical complexity and severity of patient illness along with growing expectations of patient safety. As general anesthesia drugs are commonly associated with several side effects, manufacturers are directing their investments towards the development of new formulations of existing agents or entirely new chemical entities in strides to improve safety, efficacy, recovery profile, and minimize side effects.

Considering the nature of the product, manufacturers are constantly focusing on keeping up with several regulations and guidelines on general anesthesia drugs which have been revised and updated to improve procedural safety and efficacy. Although the robotic or minimally invasive surgeries have significantly transformed the operational procedures, these processes can take longer than open surgery which may increase the possible risks of anesthesia, thereby compelling manufacturers to innovate their products with reduced side effects.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

The U.S. Takes the Center Stage

Despite many advancements in anesthesia techniques and availability of newer and safer drugs, much more scientific exploration and large clinical trials are needed to provide the greatest level of evidence and safety, prior to widespread clinical implementation.

Growth prospects of the general anesthesia drugs market are relatively high in the U.S., driven by increasing risk of organ failures and cardiac diseases among baby boomers along with significant restructuring of the healthcare system in the country. Rapid adoption of innovative business models focused on novel strategies such as seeking faster approval of drugs for reduced time-to-market and more reliance on external partners, academia, and industry consortia will continue to favor the manufacturers operating in the nation.

General Anesthesia Drugs Market Download Report Brochure

Tracking the Lasting Effects of General Anesthesia Drugs on Human Health

Although the introduction of general anesthesia drugs dates back to 1840s, they continue to associate with several side effects including elevation in blood pressure and heart rate, respiratory depression, amnesia, and even hallucinations. For example, opioid-containing anesthesia has been linked with post-surgery nausea, vomiting, and drowsiness that can hinder the patient’s recovery.

A focus on opioid-free general anesthesia, aligning with clinical strategies that include the use of multimodal analgesia and enhanced recovery after surgery (ERAS) initiatives, has been making a headway in reducing the use of addictive medications prior to surgical interventions.

Modern general anesthesia drugs have not only enabled complex surgical procedures to be performed safely on patients but also has significantly advanced human medicine. However, several studies regarding the impact of general anesthesia drugs on human health are still underway. The jury is still out as a new Israeli study links child born via C-section under general anesthesia with the risk of developing autism, while another study claims that general anesthesia in infancy has no detectable impact on brain development.

General Anesthesia Drugs Market Download Report Brochure

GENERAL ANESTHESIA DRUGS MARKET TAXONOMY

The global general anesthesia drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

By Drug Class

  • Propofol
  • Sevoflurane
  • Dexmedetomidine
  • Desflurane
  • Remifentanil
  • Midazolam
  • Others
  • (Others – Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental etc.)

By Route of Administration

  • Intravenous Anesthesia
  • Inhaled Anesthesia

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Frequently Asked Questions

The general anaesthesia drugs market is likely to record a CAGR of 3% through 2032.

The general anaesthesia drugs market size is estimated to cross US$ 6.35 Bn by 2032.

North America and Europe are likely to lead the general anaesthesia drugs market.

The general anaesthesia drugs market is likely to record a value of US$ 4.73 Bn in 2022.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

4. Key Success Factors

    4.1. Reimbursement Guidelines for Anesthesia Drugs

    4.2. Pipeline Analysis of Anesthesia Drugs

5. Global General Anesthesia Drugs Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Rising of Geriatric Population 

        6.1.2. Cost of healthcare expenditure 

    6.2. Forecast Factors - Relevance & Impact

        6.2.1. Increasing number of surgeries 

        6.2.2. New approval of anesthesia drugs 

        6.2.3. R&D investment by major players 

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity Analysis

7. Global General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2014 - 2018

    7.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Drug Class, 2019 - 2029

        7.3.1. Propofol

        7.3.2. Sevoflurane

        7.3.3. Dexmedetomidine

        7.3.4. Desflurane

        7.3.5. Remifentanil

        7.3.6. Midazolam

        7.3.7. Others

    7.4.  Market Attractiveness Analysis By Drug Class

8. Global General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Route of Administration

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) and Analysis By Route of Administration, 2014 - 2018

    8.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Route of Administration, 2019- 2029

        8.3.1. Intravenous Anesthesia

        8.3.2. Inhaled Anesthesia

    8.4.  Market Attractiveness Analysis By Route of Administration 

9. Global General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by End User

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Analysis By End User, 2014 - 2018

    9.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By End User, 2019 - 2029

        9.3.1. Hospitals

        9.3.2. Speciality Clinics

        9.3.3. Ambulatory Surgical Centers

    9.4.  Market Attractiveness Analysis By End User

10. Global General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) and Analysis By Region, 2014 - 2018

    10.3. Current Market Size (US$ Mn) and Analysis and Forecast By Region, 2019 - 2029

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. South Asia

        10.3.5. East Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa

    10.4. Market Attractiveness Analysis By Region

11. North America General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        11.3.1.  By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Drug Class

        11.3.3. By Route of Administration

        11.3.4. By End User

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Drug Class

        11.4.3. By Route of Administration

        11.4.4. By End User

    11.5. Drivers and Restraints - Impact Analysis

12. Latin America General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        12.3.1.  By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Rest of Latin America

        12.3.2. By Drug Class

        12.3.3. By Route of Administration

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Drug Class

        12.4.3. By Route of Administration

        12.4.4. By End User

    12.5. Drivers and Restraints - Impact Analysis

13. Europe General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        13.3.1.  By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Russia

            13.3.1.8. Rest of Europe

        13.3.2. By Drug Class

        13.3.3. By Route of Administration

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Drug Class

        13.4.3. By Route of Administration

        13.4.4. By End User

    13.5. Drivers and Restraints - Impact Analysis

14. South Asia General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        14.3.1.  By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Indonesia

            14.3.1.4. Malaysia

            14.3.1.5. Rest of South Asia

        14.3.2. By Drug Class

        14.3.3. By Route of Administration

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Drug Class

        14.4.3. By Route of Administration

        14.4.4. By End User

    14.5. Drivers and Restraints - Impact Analysis

15. East Asia General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        15.3.1.  By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Drug Class

        15.3.3. By Route of Administration

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Drug Class

        15.4.3. By Route of Administration

        15.4.4. By End User

    15.5. Drivers and Restraints - Impact Analysis

16. Oceania General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        16.3.1.  By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Drug Class

        16.3.3. By Route of Administration

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Drug Class

        16.4.3. By Route of Administration

        16.4.4. By End User

    16.5. Drivers and Restraints - Impact Analysis

17. Middle East and Africa General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    17.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        17.4.1.  By Country

            17.4.1.1. GCC Countries

            17.4.1.2. Turkey

            17.4.1.3. Northern Africa

            17.4.1.4. South Africa

            17.4.1.5. Rest of Middle East and Africa

        17.4.2. By Drug Class

        17.4.3. By Route of Administration

        17.4.4. By End User

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Drug Class

        17.5.3. By Route of Administration

        17.5.4. By End User

    17.6. Drivers and Restraints - Impact Analysis

18. Emerging Countries General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029

    18.1. Introduction

        18.1.1. Global Vs. Country Growth Comparison

    18.2. Brazil General Anesthesia Drugs Market Analysis

        18.2.1. Introduction

        18.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            18.2.2.1. By Drug Class

            18.2.2.2. By Route of Administration

            18.2.2.3. By End User

    18.3. Drivers and Restraints - Impact Analysis

    18.4. China General Anesthesia Drugs Market Analysis

        18.4.1. Introduction

        18.4.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            18.4.2.1. By Drug Class

            18.4.2.2. By Route of Administration

            18.4.2.3. By End User

    18.5. Drivers and Restraints - Impact Analysis

    18.6. India General Anesthesia Drugs Market Analysis

        18.6.1. Introduction

        18.6.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            18.6.2.1. By Drug Class

            18.6.2.2. By Route of Administration

            18.6.2.3. By End User

    18.7. Drivers and Restraints - Impact Analysis

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Deep Dive 

        19.2.1. Baxter International Inc.

            19.2.1.1. Overview

            19.2.1.2. Key Financials

            19.2.1.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.1.4. Key Development

            19.2.1.5. Strategy Overview

                19.2.1.5.1. Marketing Strategy

                19.2.1.5.2. Product Strategy

                19.2.1.5.3. Channel Strategy

        19.2.2. AstraZeneca

            19.2.2.1. Overview

            19.2.2.2. Key Financials

            19.2.2.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.2.4. Key Development

            19.2.2.5. Strategy Overview

                19.2.2.5.1. Marketing Strategy

                19.2.2.5.2. Product Strategy

                19.2.2.5.3. Channel Strategy

        19.2.3. AbbVie Inc. 

            19.2.3.1. Overview

            19.2.3.2. Key Financials

            19.2.3.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.3.4. Key Development

            19.2.3.5. Strategy Overview

                19.2.3.5.1. Marketing Strategy

                19.2.3.5.2. Product Strategy

                19.2.3.5.3. Channel Strategy

        19.2.4. B. Braun Melsungen AG

            19.2.4.1. Overview

            19.2.4.2. Key Financials

            19.2.4.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.4.4. Key Development

            19.2.4.5. Strategy Overview

                19.2.4.5.1. Marketing Strategy

                19.2.4.5.2. Product Strategy

                19.2.4.5.3. Channel Strategy

        19.2.5. Fresenius SE & Co. KgaA

            19.2.5.1. Overview

            19.2.5.2. Key Financials

            19.2.5.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.5.4. Key Development

            19.2.5.5. Strategy Overview

                19.2.5.5.1. Marketing Strategy

                19.2.5.5.2. Product Strategy

                19.2.5.5.3. Channel Strategy

        19.2.6. Pfizer

            19.2.6.1. Overview

            19.2.6.2. Key Financials

            19.2.6.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.6.4. Key Development

            19.2.6.5. Strategy Overview

                19.2.6.5.1. Marketing Strategy

                19.2.6.5.2. Product Strategy

                19.2.6.5.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 02: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 03: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 04: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region

Table 05: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 06: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 07: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 08: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 09: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 10: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 11: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 12: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 13: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 14: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 15: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 16: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 17: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 18: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 19: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 20: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 21: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 22: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 23: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 24: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 25: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 26: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 27: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 28: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 29: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 30: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 31: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 32: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 33: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 34: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 35: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 36: China General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 37: China General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 38: China General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 39: India General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 40: India General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 41: India General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 02: Global General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 03: Global General Anesthesia Drugs Market Absolute $ Opportunity, 2019–2029

Figure 04: General Anesthesia Drugs Market Forecast Factors – Relevance and Impact

Figure 05: Global General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 06: Global General Anesthesia Drugs Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 07: Global General Anesthesia Drugs Market Analysis by Product type–2019 & 2029

Figure 08: Global General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 09: Global General Anesthesia Drugs Market Y-o-Y Growth Projections Route of Administration, 2019 – 2029

Figure 10: Global General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 11: Global General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 12: Global General Anesthesia Drugs Market Y-o-Y Growth Projections End User, 2019 – 2029

Figure 13: Global General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 14: Global General Anesthesia Drugs Market Analysis by Region–2019 & 2029

Figure 15: Global General Anesthesia Drugs Market Y-o-Y Growth Projections Region, 2019 – 2029

Figure 16: Global General Anesthesia Drugs Market Analysis by Region–2019 & 2029

Figure 17: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 18: North America General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 19: North America General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 20: North America General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 21: North America General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 22: North America General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 23: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 24: Latin America General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 25: Latin America General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 26: Latin America General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 27: Latin America General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 28: Latin America General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 29: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 30: Europe General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 31: Europe General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 32: Europe General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 33: Europe General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 34: Europe General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 35: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 36: South Asia General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 37: South Asia General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 38: South Asia General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 39: South Asia General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 40: South Asia General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 41: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 42: East Asia General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 43: East Asia General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 44: East Asia General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 45: East Asia General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 46: East Asia General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 47: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 48: Oceania General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 49: Oceania General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 50: Oceania General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 51: Oceania General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 52: Oceania General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 53: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 54: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 55: Middle East and Africa General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 56: Middle East and Africa General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 57: Middle East and Africa General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 58: Middle East and Africa General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 59: Emerging Countries Market Value Share (2019) 

Figure 60: Emerging Countries General Anesthesia Drugs Market Value (US$ Mn), By Key Countries, 2019-2029

Figure 61: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 62: Brazil  General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 63: Brazil  General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 64: Brazil  General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 65: Brazil General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 66: China General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 67: China General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 68: China General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 69: China General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 70: China General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 71: India General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 72: India General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 73: India General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 74: India General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 75: India General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Extended Release Drugs Market

Published : June 2019

Healthcare

Orphan Drugs Market

Published : February 2016

Healthcare

Systemic Lupus Erythematous SLE Drugs Market

Published : March 2022

Healthcare

Companion Animal Drugs Market

Published : October 2019

Google translate

General Anesthesia Drugs Market